Home▸Articles▸Medicine & Biophysics

PBPK Compartment Model: Understanding Drug Distribution in the Body

A sophisticated mathematical framework that predicts how drugs move through the body, aiding in drug development and dosing optimization.

mysimulator teamUpdated June 2026≈ 3 min read▶ Open the simulation

What is a PBPK Model?

A physiologically-based pharmacokinetic (PBPK) model is a mathematical representation of the body's physiological compartments that describe how drugs are absorbed, distributed, metabolized, and excreted. This model integrates knowledge of physiology with pharmacokinetics to predict drug behavior within the body.

In this 2D PBPK simulator, each compartment represents a different tissue or organ, such as blood, liver, kidney, fat, and rest-of-body tissues, allowing for detailed analysis of drug distribution patterns.

How Does the Model Work?

The model is based on a series of differential equations that describe the rate at which drugs move between compartments. These equations take into account blood flow rates, tissue-specific partition coefficients (which determine how well a drug binds to tissues), and hepatic and renal clearance rates.

By adjusting parameters such as IV bolus dose, drug lipophilicity, and clearance multipliers, users can observe the impact of these factors on drug distribution and concentration over time.

live demo · related simulation● LIVE

Why Does It Matter?

Understanding PBPK models is crucial for optimizing drug dosing regimens to achieve therapeutic efficacy while minimizing side effects. By accurately predicting how a drug will behave in the body, researchers can design more effective and safer medications.

PBPK models are also used in regulatory submissions to support drug approval processes, providing detailed pharmacokinetic data that regulators require.

Real-World Applications

PBPK models have been applied in various fields, including oncology, where they help predict the efficacy of chemotherapy drugs. They are also used to optimize dosing regimens for patients with specific conditions or genetic variations that affect drug metabolism.

In preclinical and clinical drug development, PBPK models can guide decisions on dose selection, dosing frequency, and patient stratification based on pharmacokinetic characteristics.

Frequently asked questions

How does the model account for individual differences?

PBPK models incorporate physiological parameters that vary between individuals, such as body weight, age, and organ function. These variations can be adjusted in the simulation to reflect different patient profiles.

Can PBPK models predict drug interactions?

Yes, by incorporating additional compartments for metabolizing enzymes or transporters involved in drug-drug interactions, PBPK models can simulate how one drug affects another's pharmacokinetics.

What are the limitations of PBPK models?

PBPK models rely on accurate input data and assumptions about physiological parameters. They may not capture all complex biological processes or individual variability that could affect drug behavior.

How do researchers validate PBPK models?

Validation involves comparing model predictions with experimental data from in vitro, animal studies, and clinical trials to ensure the model accurately reflects real-world pharmacokinetics.

Try it live

Everything above runs in your browser — open PBPK Compartment Model: 2D Drug Distribution Simulator and change the parameters while it is running. Nothing is installed, nothing is uploaded, the whole model lives in one tab.

▶ Open PBPK Compartment Model: 2D Drug Distribution Simulator simulation

What did you find?

Add reproduction steps (optional)